改善有效抗菌药物的公平可及:生态系统方法
本文探讨抗菌药物公平可及的多维度问题,指出研发激励不足以实现可持续公平可及,需采用涉及多方利益相关者和公私合作的生态系统方法,并在研发、监管路径、采购策略和融资机制方面提出具体干预措施。
要点
- 抗菌药物公平可及面临证据不足、注册受限、储备抗菌药物定价和供应链挑战等问题。
- 仅靠研发推拉激励不足以实现可持续且公平的抗菌药物可及。
- 改善公平可及需生态系统方法,涵盖研发、监管、采购和融资并开展公私合作。
核心结论
- 解决抗菌药物公平可及挑战需要跨部门和跨区域的协调努力,采用以公共卫生优先事项为中心的生态系统方法。
研究设计与样本
- 本文基于已发表文章、灰色文献分析和作者自身专业经验。
主要发现
- 抗菌药物公平可及的不平等因素包括最佳临床使用证据不足、注册有限、储备抗菌药物定价和供应链挑战。
- 这些问题对低收入和中等收入国家影响尤为严重,加剧了抗菌药物耐药负担。
- 研发推拉激励不足以实现可持续且公平的抗菌药物可及。
关键数值与推荐
- 具体干预措施及公私参与方的组合可能因抗菌药物、市场和卫生系统背景而异。
- 干预措施必须旨在满足公共卫生需求,同时支持能够维持质量有保证的抗菌药物生产和交付的市场。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antibiotics are indispensable to modern healthcare, yet their equitable access remains a pressing global challenge. Factors contributing to inequities include insufficient evidence for optimal clinical use, limited registration, pricing for Reserve antibiotics, and supply chain challenges. These issues disproportionately affect low- and middle-income countries, exacerbating antimicrobial resistance burdens. OBJECTIVES: This paper explores the multifaceted dimensions of inequitable antibiotic access and proposes a comprehensive framework to address the crisis. SOURCES: Published articles, grey literature analysis, and the authors' own expertise contributed to this article. CONTENT: While much attention has been paid to push-and-pull incentives for antibiotic development, these interventions are inadequate to reach sustainable and equitable access to antibiotics. Improving equitable antibiotic access requires an ecosystem approach, involving multiple stakeholders and including public-private partnerships. The paper advocates for initiatives spanning research and development, regulatory pathways, procurement strategies, and financing mechanisms and suggests concrete interventions in each of these areas. The specific interventions and mix of public and private actors may vary according to antibiotic, market, and health system context, but must be designed to meet public health needs while also supporting a market that will sustain quality-assured production and delivery of antibiotics. IMPLICATIONS: Addressing the challenge of equitable antibiotic access requires coordinated efforts across sectors and regions. By embracing an ecosystem approach centred on public health priorities, stakeholders can pave the way for a sustainable supply of antibiotics, and equitable access, safeguarding the future of global healthcare amidst the growing threat of antimicrobial resistance.
引用
- Cohn J, Balasegaram M, Srinivasan H, et al. Improving equitable access for effective antibacterial: an ecosystem approach. Clin Microbiol Infect. 2024. PMID: 38909688. doi:10.1016/j.cmi.2024.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。